1:paclitaxel

2 trials

Sponsors

The First Affiliated Hospital of Suzhou University, Jilin Provice Cancer Hospital

Conditions

Small cell lung cancernewly diagnosed ovarian cancer

Phase 2

Neoadjuvant chemotherapy combined with tislelizumab in the treatment of newly diagnosed ovarian cancer: a single arm, single center, phase II study

Active, not recruitingChiCTR2000040760

The First Affiliated Hospital of Suzhou Universitynewly diagnosed ovarian cancer

Start: 2021-03-01Updated: 2021-07-05

A phase II study of PM8002 injection in combination with paclitaxel injection as second line treatment for small cell lung cancer(SCLC)

Active, not recruitingChiCTR2200059911

Jilin Provice Cancer HospitalSmall cell lung cancer

Start: 2022-05-01Updated: 2024-04-08